emoxypine succinate has been researched along with Diabetes Mellitus, Type 2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pugacheva, EL | 1 |
| Shishkova, VN | 1 |
| Chipova, DT; Dolgova, NA; Nikolaev, YA; Shchepankevich, LA | 1 |
| Chashchina, EN; Moskvicheva, MG; Volchegorskiĭ, IA | 2 |
| Balabolkin, MI; Klebanova, EM; Kreminskaia, VM; Smirnov, LD | 1 |
1 review(s) available for emoxypine succinate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention].
Topics: Antioxidants; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Endothelium, Vascular; Humans; Metabolic Syndrome; Oxidative Stress; Picolines | 2015 |
2 trial(s) available for emoxypine succinate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome].
Topics: Aged; Antioxidants; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Picolines; Prospective Studies; Succinates; Systole; Time Factors; Treatment Outcome; Ventricular Function, Left | 2005 |
[Lipid reducing and antioxidant action of mexicor in patients with diabetes mellitus type 2].
Topics: Antioxidants; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Follow-Up Studies; Humans; Insulin; Lipid Peroxidation; Lipids; Picolines; Treatment Outcome | 2006 |
3 other study(ies) available for emoxypine succinate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Efficacy of Mexidol in patients with type 2 diabetes mellitus with neurological complications].
Topics: Antioxidants; Brain Ischemia; Diabetes Mellitus, Type 2; Humans; Picolines; Quality of Life | 2022 |
[Optimization of hypolipidemic therapy in patients with ischemic stroke and diabetes mellitus].
Topics: beta-Thromboglobulin; Blood Platelets; Diabetes Mellitus, Type 2; Female; Hemostasis; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Picolines; Prospective Studies; Stroke; Treatment Outcome; von Willebrand Factor | 2016 |
[An effect of antioxidant drugs on symptoms of sensomotor polyneuropathy and affective disorders in patients with diabetes mellitus].
Topics: Aged; Antioxidants; Anxiety Disorders; Data Interpretation, Statistical; Depressive Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Picolines; Psychotropic Drugs; Time Factors; Treatment Outcome | 2005 |